Cargando…

Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer

Background: In recent years, great improvement has been made in immunotherapies for non-small cell lung cancer (NSCLC). Current data have suggested that Programmed cell death ligand 1 (PD-L1) expression might not be an ideal marker for patient selection in isolation. Evidence has been increasing tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinyue, Cao, Lianjing, Li, Shouying, Wang, Fan, Huang, Dingzhi, Jiang, Richeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856879/ https://www.ncbi.nlm.nih.gov/pubmed/31777599 http://dx.doi.org/10.7150/jca.34469

Ejemplares similares

PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level
por: Cao, Lianjing, et al.
Publicado: (2017)

Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements
por: Li, Shouying, et al.
Publicado: (2019)

Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer
por: Wang, Jing, et al.
Publicado: (2023)

Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer
por: Jiang, Richeng, et al.
Publicado: (2016)

Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma
por: Zhi, Qiongjie, et al.
Publicado: (2016)

PD-L1(+)NEUT, Foxp3(+)Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma
por: Zhou, Lin, et al.
Publicado: (2021)

Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma
por: Lin, Zhi-qiang, et al.
Publicado: (2022)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
por: Ameratunga, Malaka, et al.
Publicado: (2016)

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer
por: Lin, Gen, et al.
Publicado: (2017)

Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer
por: Lang, C., et al.
Publicado: (2022)

Prognostic value of PD‐L1 expression in combination with CD8(+) TILs density in patients with surgically resected non‐small cell lung cancer
por: Yang, Hui, et al.
Publicado: (2017)

PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis
por: Tuminello, Stephanie, et al.
Publicado: (2020)

Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB
por: Chen, Jia, et al.
Publicado: (2022)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

MPR and NLR as Prognostic Markers in ICU-Admitted Patients with COVID-19 in Jazan, Saudi Arabia
por: Mobarki, Abdullah A, et al.
Publicado: (2021)

A New Marker to Determine Prognosis of Acute Pancreatitis: PLR and NLR Combination
por: Kaplan, Mustafa, et al.
Publicado: (2018)

NLR-parser: rapid annotation of plant NLR complements
por: Steuernagel, Burkhard, et al.
Publicado: (2015)

Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone
por: Zhan, Xiaoli, et al.
Publicado: (2017)

Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker
por: Seyfi, Shahram, et al.
Publicado: (2023)

Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting
por: Toori, Kaleem Ullah, et al.
Publicado: (2021)

NLR, d-NLR and PLR can be affected by many factors
por: Bedel, Cihan, et al.
Publicado: (2021)

Prognostic value of PD-L1 expression in resected lung adenocarcinoma and potential molecular mechanisms
por: Ma, Jianli, et al.
Publicado: (2018)

Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis
por: Wei, Yong, et al.
Publicado: (2014)

Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism
por: Köse, Nuri, et al.
Publicado: (2020)

Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study
por: Zhang, Linlin, et al.
Publicado: (2023)

Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer
por: Xu, Tao, et al.
Publicado: (2020)

Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
por: Chen, Wei, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer
por: Gou, Miaomiao, et al.
Publicado: (2021)

Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer
por: Cen, Bo, et al.
Publicado: (2021)

The detection value of PD-L1 expression in biopsy specimens and surgical resection specimens in non-small cell lung cancer: a meta-analysis
por: Wang, Yang, et al.
Publicado: (2021)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

Circulatory YKL-40 & NLR: Underestimated Prognostic Indicators in Diffuse Glioma
por: Gandhi, Puneet, et al.
Publicado: (2018)

Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases
por: Ozyurek, Berna Akinci, et al.
Publicado: (2017)

Prognostic Role of NLR, PLR and MHR in Patients With Idiopathic Pulmonary Fibrosis
por: Chen, Yiran, et al.
Publicado: (2022)

PD-L1 expression in pulmonary lymphoepithelioma-like carcinoma: is it a prognostic biomarker?
por: Li, Wen, et al.
Publicado: (2022)

HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma
por: Pan, Bin, et al.
Publicado: (2015)

NLR and PLR in Schizophrenia
por: Surati, Love, et al.
Publicado: (2022)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
por: Yang, Ai-Ping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8031b5s2m07hja24d5ipbirjug